0
Es befinden sich keine Waren im Warenkorb !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Start > HTT

HTT

Brief Information

Name:Huntingtin
Target Synonym:Huntingtin,HD protein,HD,HTT,Huntington Disease Protein,IT15,Huntingtin (Huntington Disease),LOMARS,Huntingtin Protein
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Phase 3 Clinical

Product ListCompare or Buy

Nach Produktstatus:
Nach Produktkategorie :
Nach Arten:
Nach Markierungen:
Nach Konjugaten:
Kat. Nr. Arten Produktbeschreibung Struktur Reinheit Merkmal
HTT-H51M5 Human Human HTT Protein, MBP,His Tag (MALS verified)
HTT-H51M5-structure
HTT-H51M5-sds
ACRO Quality

Part of Bioactivity data

HTT-H51M5-ELISA
HTT MALS images

The purity of Human HTT, MBP,His Tag (Cat. No. HTT-H51M5) is more than 85% and the molecular weight of this protein is around 62-80 kDa verified by SEC-MALS.

Synonym Name

HTT,Htt,Huntingtin

Background

Huntingtin is the protein coded for by the HTT gene. Autosomal dominant mutation in the Huntingtin (Htt) protein is the cause of Huntington’s Disease (HD). In HD, the polyglutamine (polyQ) domain  in the N-terminal sequenceof the protein is expanded beyond a threshold of 36 glutamines. mutant polyQ expansion strongly correlates in an inverse manner to disease age of onset.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
WVE-003 WVE-003 Phase 2 Clinical Wave Life Sciences Ltd Huntington Disease Details
PTC-518 PTC-518 Phase 2 Clinical Ptc Therapeutics Inc Huntington Disease Details
Tominersen RG-6042; RO-7234292; ISIS-443139 Phase 3 Clinical Ionis Pharmaceuticals Inc, F. Hoffmann-La Roche Ltd Huntington Disease Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland

Nachricht schicken